95 related articles for article (PubMed ID: 18079623)
1. Bi-weekly irinotecan hydrochloride and cisplatin as a second-line chemotherapy for patients with advanced gastric cancer.
Suzuki S; Harada N; Takeo Y; Tanaka S; Hayashi T; Suzuki M; Hanyu F
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2245-8. PubMed ID: 18079623
[TBL] [Abstract][Full Text] [Related]
2. Second-line chemotherapy with combined irinotecan and low-dose cisplatin for patients with metastatic gastric carcinoma resistant to 5-fluorouracil.
Shimada S; Yagi Y; Kuramoto M; Aoki N; Ogawa M
Oncol Rep; 2003; 10(3):687-91. PubMed ID: 12684644
[TBL] [Abstract][Full Text] [Related]
3. Second-line chemotherapy with low-dose CPT-11 and cisplatin for colorectal cancer resistant to 5-FU-based chemotherapy.
Yoshimatsu K; Kato H; Ishibashi K; Hashimoto M; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Iwasaki K; Ogawa K
Cancer Chemother Pharmacol; 2003 Dec; 52(6):465-8. PubMed ID: 12920569
[TBL] [Abstract][Full Text] [Related]
4. [Second-line chemotherapy with bi-weekly CPT-11 and cisplatin for recurrent colorectal cancer resistant to 5-FU based chemotherapy].
Suzuki S; Harada N; Takeo Y; Tanaka S; Hayashi T; Suzuki M; Hanyu F
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1007-10. PubMed ID: 16044963
[TBL] [Abstract][Full Text] [Related]
5. Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin.
Shimoyama R; Yasui H; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamazaki K; Taku K; Kojima T; Machida N; Todaka A; Tomita H; Sakamoto T; Tsushima T
Gastric Cancer; 2009; 12(4):206-11. PubMed ID: 20047125
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
[TBL] [Abstract][Full Text] [Related]
7. Retrospective evaluation of sequential outpatient chemotherapy for advanced gastric cancer.
Satoh S; Kawashima K; Matsumoto S; Hasegawa S; Okabe H; Nomura A; Yoshibayashi H; Watanabe G; Nagayama S; Fukushima M; Sakai Y
Chemotherapy; 2007; 53(3):226-32. PubMed ID: 17356271
[TBL] [Abstract][Full Text] [Related]
8. Phase 1/11 study of bi-weekly irinotecan plus cisplatin in the treatment of advanced gastric cancer.
Koizumi W; Kurihara M; Satoh A; Takiuchi H; Tanabe S; Shimada K; Iwasaki R; Saigenji K
Anticancer Res; 2005; 25(2B):1257-62. PubMed ID: 15865075
[TBL] [Abstract][Full Text] [Related]
9. Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma.
Ajani JA; Baker J; Pisters PW; Ho L; Mansfield PF; Feig BW; Charnsangavej C
Oncology (Williston Park); 2002 May; 16(5 Suppl 5):16-8. PubMed ID: 12109800
[TBL] [Abstract][Full Text] [Related]
10. [A case of long-term survival of unresectable-advanced gastric cancer due to chemotherapy].
Kita K; Takahashi M; Nakano S; Akabane H; Yanagida N; Shomura H; Hanamoto T; Kuji M; Oikawa F; Miyagi H
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2281-3. PubMed ID: 20037396
[TBL] [Abstract][Full Text] [Related]
11. Third-line chemotherapy with paclitaxel, irinotecan hydrochloride and cisplatin for recurrent gastric cancer: a case report.
Takahashi N; Suzuki H; Iwabuchi S; Yamazaki Y; Yanaga K
Hepatogastroenterology; 2005; 52(61):326-8. PubMed ID: 15783061
[TBL] [Abstract][Full Text] [Related]
12. [A case of advanced gastric cancer treated with neoadjuvant chemotherapy of low-dose CPT-11 + CDDP].
Tadatomo H; Suzuki K; Ando M; Yamashita S; Tanaka K; Maruyama S; Harada Y; Ohnuma S; Sakaniwa N; Koyanagi Y
Gan To Kagaku Ryoho; 2001 Jun; 28(6):821-4. PubMed ID: 11432351
[TBL] [Abstract][Full Text] [Related]
13. CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study.
Ajani JA; Baker J; Pisters PW; Ho L; Mansfield PF; Feig BW; Charnsangavej C
Cancer; 2002 Feb; 94(3):641-6. PubMed ID: 11857295
[TBL] [Abstract][Full Text] [Related]
14. Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
Popov I; Radosevic-Jelic L; Jezdic S; Milovic M; Borojevic N; Stojanovic S; Stankovic V; Josifovski T; Kezic I
J BUON; 2008; 13(4):505-11. PubMed ID: 19145671
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic study of two infusion schedules of irinotecan combined with cisplatin in patients with advanced gastric cancer.
Fujitani K; Tsujinaka T; Hirao M
Oncology; 2003; 64(2):111-5. PubMed ID: 12566907
[TBL] [Abstract][Full Text] [Related]
17. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
Jagasia MH; Langer CJ; Johnson DH; Yunus F; Rodgers JS; Schlabach LL; Cohen AG; Shyr Y; Carbone DP; Devore RF
Clin Cancer Res; 2001 Jan; 7(1):68-73. PubMed ID: 11205920
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of weekly irinotecan/cisplatin in advanced esophageal cancer.
Ilson DH
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):22-5. PubMed ID: 15685830
[TBL] [Abstract][Full Text] [Related]
19. [Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer].
Shoji T; Takatori E; Murai M; Hatayama S; Omi H; Kagabu M; Honda T; Kumagai S; Morohara Y; Yoshizaki A; Sugiyama T; Kaido Y; Miura F; Satoh A
Gan To Kagaku Ryoho; 2010 Apr; 37(4):643-8. PubMed ID: 20414019
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer.
Ueda S; Hironaka S; Boku N; Fukutomi A; Yoshino T; Onozawa Y
Gastric Cancer; 2006; 9(3):203-7. PubMed ID: 16952039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]